Our AI
Privacy
15 minute meeting
To explore personalized outperforming therapies.
Our AI
Privacy
15 minute meeting
To explore personalized outperforming therapies.


RARE DISEASE
Cleft lip with or without cleft palate
Cleft lip with or without cleft palate
Cleft lip with or without cleft palate
Synonyms: Tessier cleft number 1,2
Synonyms: Tessier cleft number 1,2
Synonyms: Tessier cleft number 1,2
Drug discovery
346
papers
On emerging therapies
Rare developmental defect during embryogenesis
Cleft lip with or without cleft palate
Overview
Cleft lip with or without cleft palate (CL/P) is a congenital craniofacial anomaly caused by incomplete fusion of facial structures during embryonic development, resulting in openings in the upper lip, palate, or both. Affecting feeding, speech, hearing, and facial aesthetics, it requires multidisciplinary care involving surgical repair, speech therapy, orthodontics, and psychosocial support [1][3][16].
Burden
Mortality rates reach 20.3/1000 CL/P births (vs. 8.4/1000 general population) [4].
Healthcare costs are 6× higher than unaffected peers, with median lifetime costs exceeding $73,000 [12][19].
Untreated cases incur severe psychosocial impacts and increased risks of malnutrition, dental caries, and hearing loss [9][14].
Therapies
Surgical repair: Lip closure at 3–6 months, palate repair at 6–18 months, and subsequent jaw/rhinoplasty procedures in adolescence [3][13][18].
Multidisciplinary care: Teams include plastic surgeons, orthodontists, speech-language pathologists, and audiologists; 40% require speech surgery by age 5 [6][16].
Adjunctive therapies: Ear tube placement (25–50% of cases), presurgical orthopedics, and bone grafts for dental alignment [1][8][11].
Categories: rare developmental anomalies during embryogenesis, rare surgical maxillo-facial diseases
Research Papers
346 drug discovery papers about Cleft lip with or without cleft palate. Recent publications:
346 drug discovery papers about Cleft lip with or without cleft palate. Recent publications:
categories:
Small molecules
gene therapies
2025-12-11 | Compound inheritance of EHHADH and MASP1 mutations contributes to nonsyndromic cleft lip: familial analysis and zebrafish models.
Cleft lip with or without cleft palate (CL/P) represents one of the most common congenital craniofacial anomalies. Its complex genetic etiology remains incompletely understood. This study investigated compound inheritance of mutations in the EHHADH and MASP1 genes in a Polish family with three affected individuals using whole-genome sequencing and bioinformatic analysis, followed by zebrafish functional validation. We identified mutations in both genes that segregated with the CL/P phenotype. Network analysis demonstrated significant functional associations between these genes, with enrichment for innate immune response pathways. Using zebrafish models, we validated the phenotypic consequences of these mutations through mRNA injection experiments. Individual or combined injections of mutant EHHADH and MASP1 mRNAs resulted in craniofacial abnormalities, with co-injection producing the most severe phenotypes, including cleft formation. Alcian Blue staining revealed significant alterations in cartilage development, particularly in the ceratohyal angle and chondrocyte morphology. These changes may affect extracellular matrix composition and cartilage biomechanics, potentially disrupting the structural integrity and mechanical properties essential for proper craniofacial morphogenesis. Our findings suggest the possibility of a novel genetic mechanism for nonsyndromic CL/P involving the interaction between metabolic processes regulated by EHHADH and immune signaling pathways controlled by MASP1. This study expands our understanding of the genetic complexity underlying CL/P and highlights the potential intersection of immune regulation and metabolic processes in craniofacial development.
2025-10-01 | Genetic Modulation Of Irf6 Confers Nscl/P By Dna Methylation
By combining epigenetic and genome-wide association studies (GWAS), our study provides an in-depth analysis of the mechanisms regulating methylation dynamics and further revealing the etiological basis of non-syndromic cleft lip with or without cleft palate (NSCL/P). The samples for GWAS were obtained from 1,069 NSCL/P cases and 1,724 healthy controls collected by our group, peripheral blood and lip tissue samples from 105 NSCL/P patients were also collected for methylation sequencing. Ethics approval was obtained from our institution. This study integrated GWAS and methylation quantitative trait loci data to identify cg26035071, a methylation site in the IRF6 promoter region, as significantly correlated with cleft lip/palate risk. Through dual-luciferase reporter assays, rs6659367 was identified as a functional genetic variant regulating IRF6 expression. Correlation analysis predicted that the methylation transferase DNMT3B was significantly associated with IRF6 expression levels, subsequently validated by allele-specific chromatin immunoprecipitation and Sanger sequencing. These demonstrated that the rs6659367 T>G mutation enhances DNMT3B binding, elevates promoter methylation, suppresses IRF6 expression. Phase separation experiments revealed that DNMT3B forms liquid-liquid phase-separated condensates. Subsequently, we constructed the CRISPRoff system to precisely implement site methylation editing confirmed the functional correlation between cg26035071 and NSCL/P pathogenesis. In summary, the functional variant rs6659367 increases NSCL/P risk through enhancing DNMT3B recruitment and phase-separated condensate formation at the IRF6 promoter. This elevates cg26035071 methylation, suppresses IRF6 expression, and disrupts cellular functions.
2020-05-07 | Mutations of GADD45G in rabbits cause cleft lip by the disorder of proliferation, apoptosis and epithelial-mesenchymal transition (EMT).
The cleft lip with or without cleft palate (CL/P) is one of the most common congenital defects in humans. Genome-wide association studies (GWAS) have been widely used for identifying candidate genes, and different genes or chromosomal regions have shown strong evidence for the presence of causal genes in CL/P. To date, two independent GWAS have identified GADD45G as influencing risk for CL/P. However, there is no animal model evidence about GADD45G related to CL/P. Here, we reported the generation of a novel GADD45G mutated rabbit model by CRISPR/Cas9 and CRISPR-based BE4-Gam systems. The homozygous (GADD45G-/-) while not heterozygous (GADD45G+/-) pups died after birth due to severe craniofacial defects of unilateral or bilateral cleft lip (CL). Moreover, the disorder of proliferation, apoptosis and epithelial-mesenchymal transition (EMT) were also determined in the medial and lateral nasal processes (MNP and LNP) of the embryonic day 13 (E13) GADD45G-/- rabbits, which compared with the normal wild type (WT) rabbits. Thus, our study confirmed for the first time that loss of GADD45G lead to CL at the animal level and provided new insights into the crucial role of GADD45G for upper lip formation and fusion.
2018-01-16 | Generation and characterization of a conditional allele of Interferon Regulatory Factor 6.
Interferon Regulatory Factor 6 (IRF6) is a critical regulator of differentiation, proliferation, and migration of keratinocytes. Mutations in IRF6 cause two autosomal dominant disorders characterized by cleft lip with or without cleft palate. In addition, DNA variation in IRF6 confers significant risk for non-syndromic cleft lip and palate. IRF6 is also implicated in adult onset development and disease processes, including mammary gland development and squamous cell carcinoma. Mice homozygous for a null allele of Irf6 die shortly after birth due to severe skin, limb, and craniofacial defects, thus impeding the study of gene function after birth. To circumvent this, a conditional allele of Irf6 was generated. To validate the functionality of the conditional allele, we used three "deleter" Cre strains: Gdf9-Cre, CAG-Cre, and Ella-Cre. When Cre expression was driven by the Gdf9-Cre or CAG-Cre transgenes, 100% recombination was observed as indicated by DNA genotyping and phenotyping. In contrast, use of the Ella-Cre transgenic line resulted in incomplete recombination, despite expression at the one-cell stage. In sum, we generated a novel tool to delete Irf6 in a tissue specific fashion, allowing for study of gene function past perinatal stages. However, recombination efficiency of this allele was dictated by the Cre-driver used.
2015-10-01 | IRF6 mutation screening in non-syndromic orofacial clefting: analysis of 1521 families.
Van der Woude syndrome (VWS) is an autosomal dominant malformation syndrome characterized by orofacial clefting (OFC) and lower lip pits. The clinical presentation of VWS is variable and can present as an isolated OFC, making it difficult to distinguish VWS cases from individuals with non-syndromic OFCs. About 70% of causal VWS mutations occur in IRF6, a gene that is also associated with non-syndromic OFCs. Screening for IRF6 mutations in apparently non-syndromic cases has been performed in several modestly sized cohorts with mixed results. In this study, we screened 1521 trios with presumed non-syndromic OFCs to determine the frequency of causal IRF6 mutations. We identified seven likely causal IRF6 mutations, although a posteriori review identified two misdiagnosed VWS families based on the presence of lip pits. We found no evidence for association between rare IRF6 polymorphisms and non-syndromic OFCs. We combined our results with other similar studies (totaling 2472 families) and conclude that causal IRF6 mutations are found in 0.24-0.44% of apparently non-syndromic OFC families. We suggest that clinical mutation screening for IRF6 be considered for certain family patterns such as families with mixed types of OFCs and/or autosomal dominant transmission.
small molecules
2026-07-10 | Association of DOT1L histone methyltransferase with non-syndromic orofacial clefts in a cohort of children of African and Asian ancestry.
Non-syndromic orofacial clefts (nsOFCs), such as cleft lip, cleft lip with or without cleft palate (CL/P), and cleft palate only, are among the most common craniofacial malformations in humans. We identified a range of rare and de novo structural variants (SVs) associated with nsOFCs in a cohort of children of African and Asian ancestry from the Gabriella Miller Kids First Data Resource Center. Most of these novel candidate SVs are located in non-coding regions. More specifically, we characterized SVs associated with nsOFCs across the DOT1L (disruptor of telomeric silencing 1-like) genomic locus. DOT1L is the sole histone methyltransferase that catalyzes the mono-, di-, and trimethylation of histone H3 at lysine 79 (H3K79). In addition, our data revealed associations between specific SVs and genes encoding DOT1L complex subunits as well as downstream target genes. Single-nuclear RNA sequencing analysis demonstrated that mouse Dot1L and its associated targets are highly expressed in neural crest-derived mesenchyme enriched for key osteogenic genes essential for palate formation. Depletion of a Dot1L allele resulted in cleft palate and micrognathia in mice. Furthermore, we identified several families carrying SVs in the DOT1L locus and downstream DOT1L targets genes. These findings support an oligogenic model in which the concurrent presence of several SVs enhances susceptibility to the nsOFC phenotype. We propose that DOT1L and its targets act within the same genetic pathways to influence CL/P such that the combined effects of variants affecting these genes may be more substantial than their individual effects. Collectively, these studies establish a pivotal role for DOT1L-mediated H3K79 methylation in craniofacial development and palate formation and identify this pathway as a key contributor to the etiology of CL/P.
2026-05-31 | PAINLESS EXTRACTION IN CLEFT LIP AND PALATE PATIENTS USING COMPUTER-CONTROLLED LOCAL ANESTHETIC DELIVERY (CCLAD) FOR MAXILLARY NERVE BLOCKS
Dental treatment in pediatric patients with cleft lip and palate (CLP) presents unique challenges due to anatomical variations, altered innervation, scar tissue formation, and increased tissue sensitivity in the cleft area. Achieving effective and comfortable local anesthesia is essential, particularly when performing procedures adjacent to the cleft. A 5-year-old male patient diagnosed with unilateral left cleft lip and palate presented with pulp necrosis of tooth 62 due to deep caries. The tooth was located directly adjacent to the palatal cleft. The patient was categorized as high caries risk and demonstrated positive behavior (Frankl 3). Extraction of tooth 62 was indicated to eliminate focal infection. Local anesthesia was administered using a CCLAD system (The Wand®). Anesthetic management included topical anesthesia, Anterior Middle Superior Alveolar (AMSA) nerve block, Palatal Approach–Anterior Superior Alveolar (P-ASA) nerve block, and supplemental local infiltration with slow anesthetic deposition. Clinical signs confirmed adequate anesthesia prior to extraction. The procedure was completed successfully without intraoperative or postoperative complications. Follow-up examination revealed satisfactory healing. Careful consideration of anatomical and neurovascular variations in CLP patients is essential for successful anesthetic management. The use of CCLAD, combined with appropriate nerve block techniques and controlled anesthetic delivery, can enhance patient comfort and procedural effectiveness in pediatric cleft patients undergoing tooth extraction.
2026-03-12 | Suprazygomatic Maxillary Nerve Block is Associated with Reduced Postoperative Inpatient Opioid Requirement in Patients Undergoing Palatoplasty
Objective The objective of this study was to evaluate the efficacy of the suprazygomatic maxillary nerve block in reducing postoperative inpatient opioid requirements in patients undergoing palatoplasty for cleft palate repair. Design Retrospective cohort study Setting Tertiary care children's hospital Patients, Participants Patients with isolated cleft palate or cleft lip and palate who underwent palatoplasty at our institution between 2006 and 2025. Interventions Patients who received the suprazygomatic maxillary nerve block and a controlled cohort of patients who underwent cleft palate repair during the same time period without receiving a nerve block were assessed. Patient demographics, perioperative data, and opioid requirements within the immediate eight hours (in morphine milliequivalents [MME]) following surgery were recorded. Multivariate regression analysis was performed, with significance defined as p < .05. Main Outcome Measures Inpatient opioid requirement eight hours following surgery Results A total of 470 patients were included, with 235 (50.0%) in the nerve block group and 235 (50.0%) in the group without nerve block. When adjusting for age, sex, Veau class, and surgical approach, use of nerve block was associated with a significantly lower amount of MME administered in the first eight hours following palatoplasty (OR = 0.54, 95% CI [0.34–0.87], p = .011). Conclusions The suprazygomatic maxillary nerve block appears to be an effective technique for reducing postoperative inpatient opioid requirements in children undergoing cleft palate repair.
2026-03-04 | The Role of Green Beans and Tempeh in Boosting Vitamin B9, B6, and B12 Levels to Help Prevent Cleft Lip: A Scoping Review
Background: Cleft lip (CL), cleft palate (CP), and cleft lip and palate (CLP) are common birth defects, occurring in about 1 in 700 births, particularly in Asia and Indonesia. Vitamin deficiencies, especially B9, B6, and B12, during pregnancy are risk factors for CL. Mung beans, rich in vitamin B9, and tempeh, a plant-based source of vitamin B12, can help address these deficiencies as they promote healthy fetal development. Objective: This study evaluates the potential of mung beans and tempeh in increasing vitamins B9, B6, and B12 levels to prevent cleft lip. Method: We conducted a systematic search of the literature based on PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) and PICO criteria. Our inclusion criteria were: (1) studies discussing cleft lip or orofacial clefts; (2) studies evaluating the nutritional content of mung bean or tempe, particularly vitamin B9, vitamin B6, and vitamin B12; (3) articles published in English or Indonesian; (4) full original research articles available in complete text; and (5) publication year between 2015 and 2024. Articles without clear methodology, review articles, or studies not related to the targeted nutrients were excluded. Results: Thirteen articles published between 2015 and 2024 met the eligibility criteria for this scoping review. These studies originated from various countries, both developing and developed, and examined the nutritional content of mung bean and tempe as well as the roles of vitamins B9, B6, and B12 in craniofacial development. Eight studies emphasized the importance of maternal nutrition during pregnancy, identifying vitamins B9, B6, and B12 as key nutrients in preventing cleft lip and palate (CLP). These vitamins work together in the homocysteine and one-carbon cycles, which are essential for DNA synthesis and gene regulation during early facial development. Two studies highlighted the influence of epigenetic factors on CLP, noting that deficiencies in vitamin B9 or other maternal risk factors during weeks 4–8 of gestation can disrupt DNA methylation and interfere with normal lip formation. Three studies explored the nutritional benefits of mung bean and tempe. Mung beans were shown to be rich in vitamin B9 and B6, while tempe was identified as a plantbased source of vitamin B12. Evidence shows that consumption of mung bean flour can increase folate levels, supporting its potential role in reducing the risk of cleft lip. However, research on the direct impact of these foods on CL prevention is limited, highlighting the need for further studies. Conclusion: Vitamin B9, vitamin B6, and vitamin B12 play significant roles in embryonic craniofacial development, and deficiencies in these nutrients are associated with increased risk of cleft lip. Mung bean and tempe contain substantial amounts of these vitamins and therefore hold potential as affordable dietary sources to support maternal nutrition. However, current evidence remains limited regarding direct associations between consumption of these foods and cleft lip prevention. Further clinical and population-based studies are needed to confirm their preventive impact and to strengthen dietary recommendations for at-risk populations.
2025-10-08 | Emergence agitation in pediatrics after dexmedetomidine vs. sevoflurane anesthesia: A randomized controlled trial
Dexmedetomidine significantly reduces the incidence of emergence agitation without prolonging extubation time in pediatric patients undergoing cleft lip and cleft palate surgery.
cell therapies
2026-08-26 | Maxillary Distraction Osteogenesis as both Bridge to and Replacement for Orthognathic Surgery in Patients with Cleft Lip and Palate
BACKGROUND: Although maxillary distraction osteogenesis (MaxDO) has demonstrated superior bone healing in patients with cleft lip and palate (CLP), its clinical use is relatively unreported. Questions persist regarding its effectiveness in treating severe maxillary retrusion, its ability to achieve adequate dentofacial correction, and whether it is better deployed as a bridge to definitive orthognathic surgery. METHODS: The authors retrospectively reviewed all patients with a diagnosis of CLP who underwent MaxDO from 2007 through 2022 and determined predictors for long-term occlusal normalization and risk factors for relapse and additional orthognathic surgery. Chi-square tests were used for binomial variables and a multivariable logistic regression was performed. RESULTS: Twenty-six patients with CLP who underwent MaxDO for midface hypoplasia and Angle class III malocclusion between ages 9.0 and 19.2 years were included. In female patients, MaxDO achieved stable occlusion without additional surgical intervention in 83.3% of those who underwent surgery after age 13.5 years, compared with 20.0% of those who underwent surgery before age 13.5 years (P = 0.036). In male patients, MaxDO achieved stable occlusion in 50.0% of those who underwent surgery after age 17 years, compared with 0% of those who underwent surgery before age 17 years (P = 0.018). On multivariable logistic analysis, older age at time of MaxDO was associated with long-term normalization of occlusion without additional procedures (P = 0.045). CONCLUSIONS: MaxDO effectively achieves stable maxillary advancements of greater than 12 mm in patients with CLP. In young children, MaxDO may normalize severe midface hypoplasia through secondary school ages as a bridge to definitive orthognathic surgery. In skeletally mature patients, MaxDO may achieve stable normalization of occlusion without need for further orthognathic surgery.
2026-04-30 | Innovative Application of Dermofat Graft in Secondary Surgical Treatment of Cleft Lip: A Clinical Case Report
Background: Cleft lip and palate (CL/P) is a common congenital craniofacial anomaly that requires gradual management from infancy. Although primary measures such as labioplasty and palatoplasty can resolve the initial defect, secondary deformities such as lip coloboma, short columella, and disproportionate nasal contour often remain. Autologous dermofat graft is now an alternative to soft tissue augmentation with promising results.Case: An 8-year-old boy with a history of bilateral CL/P who had undergone labioplasty (2017), palatoplasty (2018), and alveolar bone graft (2023-2024), presented with complaints of asymmetrical lip and nasal shape. Examination revealed bilateral lip coloboma, nasal dorsum defect, and thickened postoperative scars. The patient was in good systemic condition and fit for surgery.Methods: Secondary correction procedures of re-labioplasty, Mulliken technique primary rhinoplasty, columella lengthening, and dermofat graft augmentation from the right gluteal fold were performed. The graft was fixed to the nasal dorsum and lip, with a reverse-U incision design and layered suturing. The patient received structured postoperative care and family education.Discussion: The use of dermofat graft has been shown to be safe and effective in improving soft tissue volume in CL/P patients. The literature supports the effectiveness of this technique in improving lip and nasal contours, with minimal complications. This approach is also relevant for regional hospitals with limited resources.Conclusion: The application of dermofat graft as part of secondary correction of CL/P shows satisfactory aesthetic results, without major complications, and can be a viable alternative in soft tissue-based craniofacial reconstructive surgery.
2026-03-01 | Use of Mesenchymal Stem Cells in Facial Bone Tissue Regeneration: An Overview of the Present
BACKGROUND: Tissue engineering, particularly utilizing mesenchymal stem cells (MSCs), represents a rapidly advancing strategy for craniofacial bone regeneration. While traditional autologous bone grafting remains the standard, its widespread application is severely limited by donor site morbidity, prolonged recovery, and inconsistent results. PURPOSE: This scoping review aims to map and evaluate the current clinical evidence regarding the application and efficacy of MSCs in human subjects undergoing craniofacial bone regeneration and rehabilitation surgeries, seeking to answer the following research question: In patients with craniofacial anomalies, does the use of MSCs in surgical rehabilitation improve the quality and amount of bone regeneration compared with traditional surgical approaches without MSCs? STUDY SELECTION: Conducted following the Preferred Reporting Items for Systematic reviews and Meta-Analyses-extension for Scoping Reviews guidelines, a Boolean literature search was executed across PubMed, Cochrane Library, and BVS (Virtual Health Library, translated into English). Inclusion criteria focused on primary human clinical studies or reports assessing MSCs for maxillofacial bone defects. Only 2 primary clinical studies met the final inclusion criteria, supplemented by selected clinical reports, which reflects the early stage of high-level evidence in this domain. RESULTS: Four studies were included in the final analysis-two identified through database searching and 2 through other sources-representing approximately 6.5% of the total records identified (n = 62). The analysis of the 2 primary studies and supporting reports suggests that MSC-based therapies, specifically those using deciduous dental pulp stem cells and bone marrow-derived MSCs, successfully promote clinically relevant bone regeneration. For alveolar cleft repair, deciduous dental pulp stem cells combined with scaffolds achieved bone formation comparable to traditional grafts, but with the key advantages of reduced morbidity. Bone marrow-derived MSCs integrated into resorbable scaffolds showed similar results to iliac crest grafts yet significantly decreased patient pain, hospitalization time, and costs. Furthermore, nasal septum chondroprogenitor cells showed early potential for managing mandibular condylar resorption. CONCLUSIONS AND RELEVANCE: MSC therapies offer a biologically superior, less invasive approach to craniofacial bone defects in comparison with traditional iliac crest bone grafts, showing promising early results for conditions like cleft lip/palate and TMJ disorders. Their relevance lies in the potential to replace morbid autologous grafts.
2025-10-17 | Is a Vomer Flap at Primary Palatoplasty Associated With the Formation of a Bony Palatal Bridge?
Objective The presence of a bony palatal bridge at the time of alveolar cleft grafting has been shown to improve bone graft outcomes. The purpose of this study was to determine if there is an association between palate repair with a vomer flap and formation of a bony palatal bridge in patients with cleft lip and palate. Design Single-institution, retrospective cohort study. Setting Tertiary children's hospital in an urban setting. Patients Patients with cleft lip and palate who underwent primary palatoplasty between 1996 and 2017 and had cone beam computed tomography (CBCT) prior to alveolar bone grafting. Interventions Primary palatoplasty with or without vomer flap. Main Outcomes Measure(s) The presence of a bony palatal bridge on pre-alveolar bone graft CBCT. Results Of 238 patients who underwent primary palatoplasty at a mean age of 10.0 months, 225 (94.5%) had a vomer flap. Bony palatal bridge formation was observed in 128 patients (53.8%) on pre-graft CBCT scans. Among patients with a bony palatal bridge, 121 (94.5%) had a vomer flap at primary palatoplasty. No significant association was found between use of a vomer flap and bony palatal bridge formation ( p = 0.996). Secondary analyses demonstrated no significant associations with age at primary palatoplasty ( p = 0.157), history of pre-surgical orthopedics ( p = 0.777), syndromic status ( p = 0.101), or cleft type ( p = 0.408). Conclusions This study demonstrated that the use of a vomer flap during primary cleft palate repair was not associated with the formation of a bony palatal bridge. Further studies will focus on other factors that may contribute to the etiology of bony palatal bridge formation.
2025-07-01 | Characterization and analysis of stem cells from human exfoliated deciduous teeth of children with and without cleft lip and palate
Background: Stem cells from human exfoliated deciduous teeth (SHED) have been considered a promising resource for regenerative medicine due to the ease of obtainment, noninvasive collection, and availability of deciduous teeth. Aims and Objectives: This study compared the characterization of SHED between children with and without cleft lip and palate (CLP), aiming at analyzing whether autologous SHED can be considered an option to be used as an alternative in the reconstruction of alveolar clefts in individuals with CLP. Materials and Methods: Dental pulp tissues were obtained from 6 healthy deciduous teeth at the exfoliation stage, from donors aged between 4 and 12 years, and divided into the control group and cleft group. The dental pulp cells obtained in the primary culture were immunophenotypically analyzed. Cells that showed positive for expressions of the cell surface markers and negative for were collected. The cells were submitted to multilineage differentiation and morphologically analyzed. The immunophenotypic difference between the groups was analyzed using Student’s t test, with a significance level of 5% ( P < 0.05). Results: Plastic adhesion was demonstrated and high levels of mesenchymal stem cell (MSC) markers were identified in both groups, with positive expression of CD105, CD73, and CD90 (≥95% positive) and absence of hematopoietic lineage markers CD45, CD34, CD11b, CD19, and HLA RD (≤2% positive). Pulp cells demonstrated capacity for adipogenic, osteogenic, and chondrogenic differentiation. The morphological analysis identified a slightly smaller nucleus and decreased proliferative capacity in the cleft group. There was a statistically significant difference ( P = 0.042) in the comparison of the cells obtained after immunophenotypic analysis between the groups. After validating the standard criteria for defining multipotent MSCs in both groups, the isolation and characterization of SHED were confirmed in all samples. Conclusion: SHED characterization of both groups was similar. These results suggest that SHED of children with CLP may be considered an option for future investigations on the autologous use of cells for therapeutic intervention.
oligonucleotides
2025-07-28 | LncRNA FENDRR Inhibits Mitochondrial Apoptosis via TET2-Mediated DNA Demethylation of MFN1 in NSCPO.
Non-syndromic cleft palate only (NSCPO) and non-syndromic cleft lip with or without cleft palate (NSCL/P) are distinct malformations with different or partially overlapping etiologies. While NSCL/P has been extensively studied, NSCPO remains relatively understudied. Emerging evidence suggests that long noncoding RNAs (lncRNAs) contribute to craniofacial development, potentially by regulating apoptosis. This study investigated the role of FENDRR, a lncRNA previously found to be downregulated in NSCL/P, in NSCPO pathogenesis. FENDRR expression in NSCPO tissues was analyzed via RT-qPCR and fluorescence in situ hybridization. Apoptosis in human embryonic palatal mesenchymal (HEPM) cells was assessed using Western blotting, flow cytometry, and TUNEL assays. Bioinformatics, methylation-specific PCR, dual-luciferase reporter assays, and RNA immunoprecipitation were employed to examine FENDRR's interaction with MFN1. FENDRR was significantly reduced in NSCPO tissues. FENDRR knockdown disrupted mitochondrial dynamics and activated mitochondrial apoptosis in HEPM cells. Mechanistically, FENDRR formed an RNA-DNA triplex with the MFN1 promoter, recruiting TET2 to promote MFN1 transcription via promoter demethylation. FENDRR enhances MFN1 expression, maintains mitochondrial fusion, and suppresses apoptosis in HEPM cells. This study provides novel insights into the regulatory role of lncRNAs in NSCPO pathogenesis and identifies FENDRR as a potential therapeutic target.
2024-05-26 | LAMA5: A new pathogenic gene for non-syndromic cleft lip with or without cleft palate.
This study aimed to investigate the effect of LAMA5 on palatal development in mice. The palatine process of C57BL/6 J fetal mice on the embryonic day 13.5 (E13.5) was cultured in vitro via the rotating culture method. The LAMA5-shRNA adenovirus vector was constructed, then transfected into the palatal process of E13.5 for 48 h in vitro. A fluorescence microscope was used to visualize the fusion of palates. The expression of LAMA5 was also detected. The expression of ki67, cyclin D1, caspase 3, E-cadherin, vimentin and SHH signaling pathway-related signaling factors in the blank control group, the negative control group, and the LAMA5 interference group were detected after virus transfection. The bilateral palates in the LAMA5 interference group were not fused after virus transfection. PCR and WB showed that the mRNA and protein expressions of LAMA5 were decreased in the LAMA5 interference group. Furthermore, the mRNA and protein expressions of ki67, cyclin D1 and gli1 were decreased in the LAMA5 interference group, while the mRNA and protein expressions of caspase 3 were increased. However, the mRNA and protein expression of E-cadherin, vimentin, Shh and ptch1 did not significantly change in the LAMA5 interference group. LAMA5 silencing causes cleft palate by inhibiting the proliferation of mouse palatal cells and promoting apoptosis, which may not be involved in EMT. LAMA5 silencing can also cause cleft palate by interfering with the SHH signaling pathway.
2024-02-27 | E-cadherin variants associated with oral facial clefts trigger aberrant cell motility in a REG1A-dependent manner
Abstract Background Germline mutations of E-cadherin contribute to hereditary diffuse gastric cancer (HDGC) and congenital malformations, such as oral facial clefts (OFC). However, the molecular mechanisms through which E-cadherin loss-of-function triggers distinct clinical outcomes remain unknown. We postulate that E-cadherin-mediated disorders result from abnormal interactions with the extracellular matrix and consequent aberrant intracellular signalling, affecting the coordination of cell migration. Methods Herein, we developed in vivo and in vitro models of E-cadherin mutants associated with either OFC or HDGC. Using a Drosophila approach, we addressed the impact of the different variants in cell morphology and migration ability. By combining gap closure migration assays and time-lapse microscopy, we further investigated the migration pattern of cells expressing OFC or HDGC variants. The adhesion profile of the variants was evaluated using high-throughput ECM arrays, whereas RNA sequencing technology was explored for identification of genes involved in aberrant cell motility. Results We have demonstrated that cells expressing OFC variants exhibit an excessive motility performance and irregular leading edges, which prevent the coordinated movement of the epithelial monolayer. Importantly, we found that OFC variants promote cell adhesion to a wider variety of extracellular matrices than HDGC variants, suggesting higher plasticity in response to different microenvironments. We unveiled a distinct transcriptomic profile in the OFC setting and pinpointed REG1A as a putative regulator of this outcome. Consistent with this, specific RNAi-mediated inhibition of REG1A shifted the migration pattern of OFC expressing cells, leading to slower wound closure with coordinated leading edges. Conclusions We provide evidence that E-cadherin variants associated with OFC activate aberrant signalling pathways that support dynamic rearrangements of cells towards improved adaptability to the microenvironment. This proficiency results in abnormal tissue shaping and movement, possibly underlying the development of orofacial malformations. Graphical Abstract
2023-07-13 | lncRNA MIR31HG Regulates Proliferation and Migration by Targeting Matrix Gla Protein in Nonsyndromic Cleft Lip With or Without Cleft Palate.
Nonsyndromic cleft lip with or without cleft palate (NSCL/P) is a common craniofacial birth defect with complex etiologies. Recently, the dysregulation of long noncoding RNAs (lncRNAs) has been implicated in many developmental diseases, including NSCL/P. However, the functions and mechanisms of lncRNAs in NSCL/P have not been fully elucidated. In this study, we found that lncRNA MIR31HG in NSCL/P patients was significantly downregulated than that in healthy individuals (GSE42589, GSE183527). In addition, single nucleotide polymorphism rs58751040 in MIR31HG was nominally associated with NSCL/P susceptibility (odds ratio: 1.29, 95% confidence interval: 1.03-1.54, p = 4.93 × 10-2) through a case-control study (504 NSCL/P cases and 455 controls). Luciferase activity assay showed that the C allele of rs58751040 revealed a decreased transcription activity of MIR31HG than the G allele. Moreover, knockdown of MIR31HG promoted cell proliferation and migration in human oral keratinocytes and human embryonic palate mesenchyme. Bioinformatic analysis and cellular studies suggested that MIR31HG may confer susceptibility to risk of NSCL/P through matrix Gla protein (MGP) signaling. In summary, we identified a novel lncRNA involved in the development of NSCL/P.
2023-04-21 | Long non-coding RNAs MALAT1 and NEAT1 in non-syndromic orofacial clefts.
Long non-coding RNAs (lncRNAs) are thought to play important roles in non-syndromic orofacial clefts (NSOFC). Clinical diagnosis was categorized as either non-syndromic cleft lip with or without cleft palate (NSCL/P), or non-syndromic cleft palate only (NSCPO). Tissues excised from the trimmed wound edge were reserved as experimental samples; adjacent normal control was used as a positive control, and tissue from healthy individuals was used as a blank control. Target lncRNAs in the collected tissues were identified using microarrays and quantitative reverse transcription PCR (RT-qPCR). Immunohistochemical (IHC) staining and RT-qPCR were used to verify the target mRNAs. Pathway, gene ontology (GO) enrichment, and TargetScan predictions were employed to construct competing endogenous RNA networks (ceRNA networks) and explore their potential functions. RNA-Seq revealed 24 upregulated and 43 downregulated lncRNAs; MALAT1 and NEAT1 were screened and validated using RT-qPCR. Common NSOFC risk factors were positively correlated with MALAT1 and NEAT1 expression. Bioinformatics predicted four ceRNA networks; GO enrichment focused on their potential functions. RT-qPCR and IHC data were consistent with respect to expression levels of proteins and the mRNAs that encode them. As MALAT1 and NEAT1 are associated with the severity of NSOFC, they represent potential therapeutic targets and prognostic biomarkers.
other
2025-11-30 | MOLAR-INCISOR HYPOMINERALIZATION ASSOCIATED WITH CLEFT LIP AND PALATE: CLINICAL EVIDENCE AND MANAGEMENT PERSPECTIVES
Cleft lip and palate are common congenital defects, affecting approximately one in every 650 live births in Brazil. In parallel, molar-incisor hypomineralization (MIH) is a defect that manifests as demarcated opacities that often affect the tooth enamel of first molars and permanent incisors. In patients with cleft lip and palate, factors such as bone graft surgery can contribute to MIH, which has a significantly high prevalence in this group. This study aimed to conduct a literature review on incisive molar hypomineralization in patients with cleft lip and palate, analyzing its prevalence compared to individuals without fissure, risk factors, clinical implications, challenges in the management and treatment of the condition. To this end, the review analyzed publications in databases such as PubMed/Medline, Scielo, and Scopus, using the following terms: MIH; pediatric dentistry; hypomineralization; cleft lip and palate; dental treatment; rehabilitation; and prevention. Results showed that, in the first stage, seven studies related MIH to cleft lip and palate, pointing to a higher prevalence in more complex cases, without addressing clinical management. In the second stage, nine high-evidence studies on the prevention and treatment of MIH in the general population were included, with protocols that could be adapted to patients with cleft lip and palate. In conclusion, MIH is more prevalent in patients with cleft lip and palate, especially in cases involving the palate and bilateral clefts. This condition compromises function, aesthetics, and quality of life, requiring individualized management with preventive strategies, sensitivity control, and adequate restorations.
2024-03-20 | METTL3-dependent m6A modification of PSEN1 mRNA regulates craniofacial development through the Wnt/β-catenin signaling pathway
Abstract Craniofacial malformations, often associated with syndromes, are prevalent birth defects. Emerging evidence underscores the importance of m 6 A modifications in various bioprocesses such as stem cell differentiation, tissue development, and tumorigenesis. Here, in vivo, experiments with zebrafish models revealed that mettl3 -knockdown embryos at 144 h postfertilization exhibited aberrant craniofacial features, including altered mouth opening, jaw dimensions, ethmoid plate, tooth formation and hypoactive behavior. Similarly, low METTL3 expression inhibited the proliferation and migration of BMSCs, HEPM cells, and DPSCs. Loss of METTL3 led to reduced mRNA m 6 A methylation and PSEN1 expression, impacting craniofacial phenotypes. Co-injection of mettl3 or psen1 mRNA rescued the level of Sox10 fusion protein, promoted voluntary movement, and mitigated abnormal craniofacial phenotypes induced by mettl3 knockdown in zebrafish. Mechanistically, YTHDF1 enhanced the mRNA stability of m 6 A-modified PSEN1 , while decreased METTL3-mediated m 6 A methylation hindered β-catenin binding to PSEN1, suppressing Wnt/β-catenin signaling. Pharmacological activation of the Wnt/β-catenin pathway partially alleviated the phenotypes of mettl3 morphant and reversed the decreases in cell proliferation and migration induced by METTL3 silencing. This study elucidates the pivotal role of METTL3 in craniofacial development via the METTL3/YTHDF1/PSEN1/β-catenin signaling axis.
2023-03-01 | Canonical Wnt signaling regulates soft palate development by mediating ciliary homeostasis
ABSTRACT Craniofacial morphogenesis requires complex interactions involving different tissues, signaling pathways, secreted factors and organelles. The details of these interactions remain elusive. In this study, we have analyzed the molecular mechanisms and homeostatic cellular activities governing soft palate development to improve regenerative strategies for individuals with cleft palate. We have identified canonical Wnt signaling as a key signaling pathway primarily active in cranial neural crest (CNC)-derived mesenchymal cells surrounding soft palatal myogenic cells. Using Osr2-Cre;β-cateninfl/fl mice, we show that Wnt signaling is indispensable for mesenchymal cell proliferation and subsequently for myogenesis through mediating ciliogenesis. Specifically, we have identified that Wnt signaling directly regulates expression of the ciliary gene Ttll3. Impaired ciliary disassembly leads to differentiation defects in mesenchymal cells and indirectly disrupts myogenesis through decreased expression of Dlk1, a mesenchymal cell-derived pro-myogenesis factor. Moreover, we show that siRNA-mediated reduction of Ttll3 expression partly rescues mesenchymal cell proliferation and myogenesis in the palatal explant cultures from Osr2-Cre;β-cateninfl/fl embryos. This study highlights the role of Wnt signaling in palatogenesis through the control of ciliary homeostasis, which establishes a new mechanism for Wnt-regulated craniofacial morphogenesis.
2019-02-28 | The use of botulinum toxin type A to minimize scarring in cleft lip repair: A literature review
Postsurgical scars can be a major concern for many patients. Young and Hutchison [1] found that patients were usually not satisfied with their surgical scars, with 91% stating that they would value any further improvement in their scars. Cleft lip with or without cleft palate is one of the most common congenital anomalies worldwide [2] [3]. Nonsyndromic cleft lip/palate affects approximately 1.5 to 2.5 cases per 1,000 live births, and its epidemiological distribution varies by ethnicity and geographic area [4] [5]. In today's culture, there is a major emphasis on facial appearances, largely driven by advances in social media. Individuals with deviations from what is considered "a normal look" may be socially stigmatized in their communities. Therefore, the final facial scar appearance remains a significant concern for affected individuals and their families. Herein, we review the process of wound healing and summarize the literature evaluating the effects of botulinum toxin type A (BTA) on scar formation in cleft lip repair.
2019-02-22 | The Role of the Wnt Signaling Pathway in Upper Jaw Development of Chick Embryo
Cleft lip with or without cleft palate (CLP) usually results from a failure of the medial nasal prominences to fuse with the lateral and maxillary prominences. This failure inhibits facial morphogenesis regulated by several major morphogenetic signaling pathways. We hypothesized that CLP results from the failure of the Wnt signaling pathway. To examine whether Wnt signaling can influences upper jaw development, we applied beads soaked with Dickkopf-1 (Dkk-1), Alsterpaullone (AL) or Wnt3a to the right side of the maxillary prominence of the chick embryo. The embryo showed a defect of the maxilla on the treated side, and skeletal staining revealed hypoplasia of the premaxilla and palatine bone as a result of Dkk-1-soaked bead implantation. 5-bromo-2'-deoxyuridine (BrdU)-positive cell numbers in the treated maxillary prominence were significantly lower at both 24 and 48 hr after implantation. Down-regulation of the expression of Bmp4, Tbx22, Sox9, and Barx1 was confirmed in the maxillary prominence treated with Dkk-1, which indicated that the deformity of the maxillary bone was controlled by gene targets of the Wnt signaling pathway. Expression of N-cadherin was seen immunohistochemically in the maxillary prominences of embryos at 6 hr and increased at 24 hr after AL treatment. Wnt signaling enhanced by AL or Wnt3a up-regulated the expression levels of Msx1, Bmp4, Tbx22, Sox9, and Barx1. Our data suggest that the Wnt signaling pathway regulates maxillary morphogenesis and growth through Bmp4, Tbx22, Sox9, and Barx1. Wnt signaling might regulate N-cadherin expression via Msx1, resulting in cell aggregation for osteochondrogenesis.
gene therapies
2025-12-11 | Compound inheritance of EHHADH and MASP1 mutations contributes to nonsyndromic cleft lip: familial analysis and zebrafish models.
Cleft lip with or without cleft palate (CL/P) represents one of the most common congenital craniofacial anomalies. Its complex genetic etiology remains incompletely understood. This study investigated compound inheritance of mutations in the EHHADH and MASP1 genes in a Polish family with three affected individuals using whole-genome sequencing and bioinformatic analysis, followed by zebrafish functional validation. We identified mutations in both genes that segregated with the CL/P phenotype. Network analysis demonstrated significant functional associations between these genes, with enrichment for innate immune response pathways. Using zebrafish models, we validated the phenotypic consequences of these mutations through mRNA injection experiments. Individual or combined injections of mutant EHHADH and MASP1 mRNAs resulted in craniofacial abnormalities, with co-injection producing the most severe phenotypes, including cleft formation. Alcian Blue staining revealed significant alterations in cartilage development, particularly in the ceratohyal angle and chondrocyte morphology. These changes may affect extracellular matrix composition and cartilage biomechanics, potentially disrupting the structural integrity and mechanical properties essential for proper craniofacial morphogenesis. Our findings suggest the possibility of a novel genetic mechanism for nonsyndromic CL/P involving the interaction between metabolic processes regulated by EHHADH and immune signaling pathways controlled by MASP1. This study expands our understanding of the genetic complexity underlying CL/P and highlights the potential intersection of immune regulation and metabolic processes in craniofacial development.
2025-10-01 | Genetic Modulation Of Irf6 Confers Nscl/P By Dna Methylation
By combining epigenetic and genome-wide association studies (GWAS), our study provides an in-depth analysis of the mechanisms regulating methylation dynamics and further revealing the etiological basis of non-syndromic cleft lip with or without cleft palate (NSCL/P). The samples for GWAS were obtained from 1,069 NSCL/P cases and 1,724 healthy controls collected by our group, peripheral blood and lip tissue samples from 105 NSCL/P patients were also collected for methylation sequencing. Ethics approval was obtained from our institution. This study integrated GWAS and methylation quantitative trait loci data to identify cg26035071, a methylation site in the IRF6 promoter region, as significantly correlated with cleft lip/palate risk. Through dual-luciferase reporter assays, rs6659367 was identified as a functional genetic variant regulating IRF6 expression. Correlation analysis predicted that the methylation transferase DNMT3B was significantly associated with IRF6 expression levels, subsequently validated by allele-specific chromatin immunoprecipitation and Sanger sequencing. These demonstrated that the rs6659367 T>G mutation enhances DNMT3B binding, elevates promoter methylation, suppresses IRF6 expression. Phase separation experiments revealed that DNMT3B forms liquid-liquid phase-separated condensates. Subsequently, we constructed the CRISPRoff system to precisely implement site methylation editing confirmed the functional correlation between cg26035071 and NSCL/P pathogenesis. In summary, the functional variant rs6659367 increases NSCL/P risk through enhancing DNMT3B recruitment and phase-separated condensate formation at the IRF6 promoter. This elevates cg26035071 methylation, suppresses IRF6 expression, and disrupts cellular functions.
2020-05-07 | Mutations of GADD45G in rabbits cause cleft lip by the disorder of proliferation, apoptosis and epithelial-mesenchymal transition (EMT).
The cleft lip with or without cleft palate (CL/P) is one of the most common congenital defects in humans. Genome-wide association studies (GWAS) have been widely used for identifying candidate genes, and different genes or chromosomal regions have shown strong evidence for the presence of causal genes in CL/P. To date, two independent GWAS have identified GADD45G as influencing risk for CL/P. However, there is no animal model evidence about GADD45G related to CL/P. Here, we reported the generation of a novel GADD45G mutated rabbit model by CRISPR/Cas9 and CRISPR-based BE4-Gam systems. The homozygous (GADD45G-/-) while not heterozygous (GADD45G+/-) pups died after birth due to severe craniofacial defects of unilateral or bilateral cleft lip (CL). Moreover, the disorder of proliferation, apoptosis and epithelial-mesenchymal transition (EMT) were also determined in the medial and lateral nasal processes (MNP and LNP) of the embryonic day 13 (E13) GADD45G-/- rabbits, which compared with the normal wild type (WT) rabbits. Thus, our study confirmed for the first time that loss of GADD45G lead to CL at the animal level and provided new insights into the crucial role of GADD45G for upper lip formation and fusion.
2018-01-16 | Generation and characterization of a conditional allele of Interferon Regulatory Factor 6.
Interferon Regulatory Factor 6 (IRF6) is a critical regulator of differentiation, proliferation, and migration of keratinocytes. Mutations in IRF6 cause two autosomal dominant disorders characterized by cleft lip with or without cleft palate. In addition, DNA variation in IRF6 confers significant risk for non-syndromic cleft lip and palate. IRF6 is also implicated in adult onset development and disease processes, including mammary gland development and squamous cell carcinoma. Mice homozygous for a null allele of Irf6 die shortly after birth due to severe skin, limb, and craniofacial defects, thus impeding the study of gene function after birth. To circumvent this, a conditional allele of Irf6 was generated. To validate the functionality of the conditional allele, we used three "deleter" Cre strains: Gdf9-Cre, CAG-Cre, and Ella-Cre. When Cre expression was driven by the Gdf9-Cre or CAG-Cre transgenes, 100% recombination was observed as indicated by DNA genotyping and phenotyping. In contrast, use of the Ella-Cre transgenic line resulted in incomplete recombination, despite expression at the one-cell stage. In sum, we generated a novel tool to delete Irf6 in a tissue specific fashion, allowing for study of gene function past perinatal stages. However, recombination efficiency of this allele was dictated by the Cre-driver used.
2015-10-01 | IRF6 mutation screening in non-syndromic orofacial clefting: analysis of 1521 families.
Van der Woude syndrome (VWS) is an autosomal dominant malformation syndrome characterized by orofacial clefting (OFC) and lower lip pits. The clinical presentation of VWS is variable and can present as an isolated OFC, making it difficult to distinguish VWS cases from individuals with non-syndromic OFCs. About 70% of causal VWS mutations occur in IRF6, a gene that is also associated with non-syndromic OFCs. Screening for IRF6 mutations in apparently non-syndromic cases has been performed in several modestly sized cohorts with mixed results. In this study, we screened 1521 trios with presumed non-syndromic OFCs to determine the frequency of causal IRF6 mutations. We identified seven likely causal IRF6 mutations, although a posteriori review identified two misdiagnosed VWS families based on the presence of lip pits. We found no evidence for association between rare IRF6 polymorphisms and non-syndromic OFCs. We combined our results with other similar studies (totaling 2472 families) and conclude that causal IRF6 mutations are found in 0.24-0.44% of apparently non-syndromic OFC families. We suggest that clinical mutation screening for IRF6 be considered for certain family patterns such as families with mixed types of OFCs and/or autosomal dominant transmission.
small molecules
2026-07-10 | Association of DOT1L histone methyltransferase with non-syndromic orofacial clefts in a cohort of children of African and Asian ancestry.
Non-syndromic orofacial clefts (nsOFCs), such as cleft lip, cleft lip with or without cleft palate (CL/P), and cleft palate only, are among the most common craniofacial malformations in humans. We identified a range of rare and de novo structural variants (SVs) associated with nsOFCs in a cohort of children of African and Asian ancestry from the Gabriella Miller Kids First Data Resource Center. Most of these novel candidate SVs are located in non-coding regions. More specifically, we characterized SVs associated with nsOFCs across the DOT1L (disruptor of telomeric silencing 1-like) genomic locus. DOT1L is the sole histone methyltransferase that catalyzes the mono-, di-, and trimethylation of histone H3 at lysine 79 (H3K79). In addition, our data revealed associations between specific SVs and genes encoding DOT1L complex subunits as well as downstream target genes. Single-nuclear RNA sequencing analysis demonstrated that mouse Dot1L and its associated targets are highly expressed in neural crest-derived mesenchyme enriched for key osteogenic genes essential for palate formation. Depletion of a Dot1L allele resulted in cleft palate and micrognathia in mice. Furthermore, we identified several families carrying SVs in the DOT1L locus and downstream DOT1L targets genes. These findings support an oligogenic model in which the concurrent presence of several SVs enhances susceptibility to the nsOFC phenotype. We propose that DOT1L and its targets act within the same genetic pathways to influence CL/P such that the combined effects of variants affecting these genes may be more substantial than their individual effects. Collectively, these studies establish a pivotal role for DOT1L-mediated H3K79 methylation in craniofacial development and palate formation and identify this pathway as a key contributor to the etiology of CL/P.
2026-05-31 | PAINLESS EXTRACTION IN CLEFT LIP AND PALATE PATIENTS USING COMPUTER-CONTROLLED LOCAL ANESTHETIC DELIVERY (CCLAD) FOR MAXILLARY NERVE BLOCKS
Dental treatment in pediatric patients with cleft lip and palate (CLP) presents unique challenges due to anatomical variations, altered innervation, scar tissue formation, and increased tissue sensitivity in the cleft area. Achieving effective and comfortable local anesthesia is essential, particularly when performing procedures adjacent to the cleft. A 5-year-old male patient diagnosed with unilateral left cleft lip and palate presented with pulp necrosis of tooth 62 due to deep caries. The tooth was located directly adjacent to the palatal cleft. The patient was categorized as high caries risk and demonstrated positive behavior (Frankl 3). Extraction of tooth 62 was indicated to eliminate focal infection. Local anesthesia was administered using a CCLAD system (The Wand®). Anesthetic management included topical anesthesia, Anterior Middle Superior Alveolar (AMSA) nerve block, Palatal Approach–Anterior Superior Alveolar (P-ASA) nerve block, and supplemental local infiltration with slow anesthetic deposition. Clinical signs confirmed adequate anesthesia prior to extraction. The procedure was completed successfully without intraoperative or postoperative complications. Follow-up examination revealed satisfactory healing. Careful consideration of anatomical and neurovascular variations in CLP patients is essential for successful anesthetic management. The use of CCLAD, combined with appropriate nerve block techniques and controlled anesthetic delivery, can enhance patient comfort and procedural effectiveness in pediatric cleft patients undergoing tooth extraction.
2026-03-12 | Suprazygomatic Maxillary Nerve Block is Associated with Reduced Postoperative Inpatient Opioid Requirement in Patients Undergoing Palatoplasty
Objective The objective of this study was to evaluate the efficacy of the suprazygomatic maxillary nerve block in reducing postoperative inpatient opioid requirements in patients undergoing palatoplasty for cleft palate repair. Design Retrospective cohort study Setting Tertiary care children's hospital Patients, Participants Patients with isolated cleft palate or cleft lip and palate who underwent palatoplasty at our institution between 2006 and 2025. Interventions Patients who received the suprazygomatic maxillary nerve block and a controlled cohort of patients who underwent cleft palate repair during the same time period without receiving a nerve block were assessed. Patient demographics, perioperative data, and opioid requirements within the immediate eight hours (in morphine milliequivalents [MME]) following surgery were recorded. Multivariate regression analysis was performed, with significance defined as p < .05. Main Outcome Measures Inpatient opioid requirement eight hours following surgery Results A total of 470 patients were included, with 235 (50.0%) in the nerve block group and 235 (50.0%) in the group without nerve block. When adjusting for age, sex, Veau class, and surgical approach, use of nerve block was associated with a significantly lower amount of MME administered in the first eight hours following palatoplasty (OR = 0.54, 95% CI [0.34–0.87], p = .011). Conclusions The suprazygomatic maxillary nerve block appears to be an effective technique for reducing postoperative inpatient opioid requirements in children undergoing cleft palate repair.
2026-03-04 | The Role of Green Beans and Tempeh in Boosting Vitamin B9, B6, and B12 Levels to Help Prevent Cleft Lip: A Scoping Review
Background: Cleft lip (CL), cleft palate (CP), and cleft lip and palate (CLP) are common birth defects, occurring in about 1 in 700 births, particularly in Asia and Indonesia. Vitamin deficiencies, especially B9, B6, and B12, during pregnancy are risk factors for CL. Mung beans, rich in vitamin B9, and tempeh, a plant-based source of vitamin B12, can help address these deficiencies as they promote healthy fetal development. Objective: This study evaluates the potential of mung beans and tempeh in increasing vitamins B9, B6, and B12 levels to prevent cleft lip. Method: We conducted a systematic search of the literature based on PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) and PICO criteria. Our inclusion criteria were: (1) studies discussing cleft lip or orofacial clefts; (2) studies evaluating the nutritional content of mung bean or tempe, particularly vitamin B9, vitamin B6, and vitamin B12; (3) articles published in English or Indonesian; (4) full original research articles available in complete text; and (5) publication year between 2015 and 2024. Articles without clear methodology, review articles, or studies not related to the targeted nutrients were excluded. Results: Thirteen articles published between 2015 and 2024 met the eligibility criteria for this scoping review. These studies originated from various countries, both developing and developed, and examined the nutritional content of mung bean and tempe as well as the roles of vitamins B9, B6, and B12 in craniofacial development. Eight studies emphasized the importance of maternal nutrition during pregnancy, identifying vitamins B9, B6, and B12 as key nutrients in preventing cleft lip and palate (CLP). These vitamins work together in the homocysteine and one-carbon cycles, which are essential for DNA synthesis and gene regulation during early facial development. Two studies highlighted the influence of epigenetic factors on CLP, noting that deficiencies in vitamin B9 or other maternal risk factors during weeks 4–8 of gestation can disrupt DNA methylation and interfere with normal lip formation. Three studies explored the nutritional benefits of mung bean and tempe. Mung beans were shown to be rich in vitamin B9 and B6, while tempe was identified as a plantbased source of vitamin B12. Evidence shows that consumption of mung bean flour can increase folate levels, supporting its potential role in reducing the risk of cleft lip. However, research on the direct impact of these foods on CL prevention is limited, highlighting the need for further studies. Conclusion: Vitamin B9, vitamin B6, and vitamin B12 play significant roles in embryonic craniofacial development, and deficiencies in these nutrients are associated with increased risk of cleft lip. Mung bean and tempe contain substantial amounts of these vitamins and therefore hold potential as affordable dietary sources to support maternal nutrition. However, current evidence remains limited regarding direct associations between consumption of these foods and cleft lip prevention. Further clinical and population-based studies are needed to confirm their preventive impact and to strengthen dietary recommendations for at-risk populations.
2025-10-08 | Emergence agitation in pediatrics after dexmedetomidine vs. sevoflurane anesthesia: A randomized controlled trial
Dexmedetomidine significantly reduces the incidence of emergence agitation without prolonging extubation time in pediatric patients undergoing cleft lip and cleft palate surgery.
cell therapies
2026-08-26 | Maxillary Distraction Osteogenesis as both Bridge to and Replacement for Orthognathic Surgery in Patients with Cleft Lip and Palate
BACKGROUND: Although maxillary distraction osteogenesis (MaxDO) has demonstrated superior bone healing in patients with cleft lip and palate (CLP), its clinical use is relatively unreported. Questions persist regarding its effectiveness in treating severe maxillary retrusion, its ability to achieve adequate dentofacial correction, and whether it is better deployed as a bridge to definitive orthognathic surgery. METHODS: The authors retrospectively reviewed all patients with a diagnosis of CLP who underwent MaxDO from 2007 through 2022 and determined predictors for long-term occlusal normalization and risk factors for relapse and additional orthognathic surgery. Chi-square tests were used for binomial variables and a multivariable logistic regression was performed. RESULTS: Twenty-six patients with CLP who underwent MaxDO for midface hypoplasia and Angle class III malocclusion between ages 9.0 and 19.2 years were included. In female patients, MaxDO achieved stable occlusion without additional surgical intervention in 83.3% of those who underwent surgery after age 13.5 years, compared with 20.0% of those who underwent surgery before age 13.5 years (P = 0.036). In male patients, MaxDO achieved stable occlusion in 50.0% of those who underwent surgery after age 17 years, compared with 0% of those who underwent surgery before age 17 years (P = 0.018). On multivariable logistic analysis, older age at time of MaxDO was associated with long-term normalization of occlusion without additional procedures (P = 0.045). CONCLUSIONS: MaxDO effectively achieves stable maxillary advancements of greater than 12 mm in patients with CLP. In young children, MaxDO may normalize severe midface hypoplasia through secondary school ages as a bridge to definitive orthognathic surgery. In skeletally mature patients, MaxDO may achieve stable normalization of occlusion without need for further orthognathic surgery.
2026-04-30 | Innovative Application of Dermofat Graft in Secondary Surgical Treatment of Cleft Lip: A Clinical Case Report
Background: Cleft lip and palate (CL/P) is a common congenital craniofacial anomaly that requires gradual management from infancy. Although primary measures such as labioplasty and palatoplasty can resolve the initial defect, secondary deformities such as lip coloboma, short columella, and disproportionate nasal contour often remain. Autologous dermofat graft is now an alternative to soft tissue augmentation with promising results.Case: An 8-year-old boy with a history of bilateral CL/P who had undergone labioplasty (2017), palatoplasty (2018), and alveolar bone graft (2023-2024), presented with complaints of asymmetrical lip and nasal shape. Examination revealed bilateral lip coloboma, nasal dorsum defect, and thickened postoperative scars. The patient was in good systemic condition and fit for surgery.Methods: Secondary correction procedures of re-labioplasty, Mulliken technique primary rhinoplasty, columella lengthening, and dermofat graft augmentation from the right gluteal fold were performed. The graft was fixed to the nasal dorsum and lip, with a reverse-U incision design and layered suturing. The patient received structured postoperative care and family education.Discussion: The use of dermofat graft has been shown to be safe and effective in improving soft tissue volume in CL/P patients. The literature supports the effectiveness of this technique in improving lip and nasal contours, with minimal complications. This approach is also relevant for regional hospitals with limited resources.Conclusion: The application of dermofat graft as part of secondary correction of CL/P shows satisfactory aesthetic results, without major complications, and can be a viable alternative in soft tissue-based craniofacial reconstructive surgery.
2026-03-01 | Use of Mesenchymal Stem Cells in Facial Bone Tissue Regeneration: An Overview of the Present
BACKGROUND: Tissue engineering, particularly utilizing mesenchymal stem cells (MSCs), represents a rapidly advancing strategy for craniofacial bone regeneration. While traditional autologous bone grafting remains the standard, its widespread application is severely limited by donor site morbidity, prolonged recovery, and inconsistent results. PURPOSE: This scoping review aims to map and evaluate the current clinical evidence regarding the application and efficacy of MSCs in human subjects undergoing craniofacial bone regeneration and rehabilitation surgeries, seeking to answer the following research question: In patients with craniofacial anomalies, does the use of MSCs in surgical rehabilitation improve the quality and amount of bone regeneration compared with traditional surgical approaches without MSCs? STUDY SELECTION: Conducted following the Preferred Reporting Items for Systematic reviews and Meta-Analyses-extension for Scoping Reviews guidelines, a Boolean literature search was executed across PubMed, Cochrane Library, and BVS (Virtual Health Library, translated into English). Inclusion criteria focused on primary human clinical studies or reports assessing MSCs for maxillofacial bone defects. Only 2 primary clinical studies met the final inclusion criteria, supplemented by selected clinical reports, which reflects the early stage of high-level evidence in this domain. RESULTS: Four studies were included in the final analysis-two identified through database searching and 2 through other sources-representing approximately 6.5% of the total records identified (n = 62). The analysis of the 2 primary studies and supporting reports suggests that MSC-based therapies, specifically those using deciduous dental pulp stem cells and bone marrow-derived MSCs, successfully promote clinically relevant bone regeneration. For alveolar cleft repair, deciduous dental pulp stem cells combined with scaffolds achieved bone formation comparable to traditional grafts, but with the key advantages of reduced morbidity. Bone marrow-derived MSCs integrated into resorbable scaffolds showed similar results to iliac crest grafts yet significantly decreased patient pain, hospitalization time, and costs. Furthermore, nasal septum chondroprogenitor cells showed early potential for managing mandibular condylar resorption. CONCLUSIONS AND RELEVANCE: MSC therapies offer a biologically superior, less invasive approach to craniofacial bone defects in comparison with traditional iliac crest bone grafts, showing promising early results for conditions like cleft lip/palate and TMJ disorders. Their relevance lies in the potential to replace morbid autologous grafts.
2025-10-17 | Is a Vomer Flap at Primary Palatoplasty Associated With the Formation of a Bony Palatal Bridge?
Objective The presence of a bony palatal bridge at the time of alveolar cleft grafting has been shown to improve bone graft outcomes. The purpose of this study was to determine if there is an association between palate repair with a vomer flap and formation of a bony palatal bridge in patients with cleft lip and palate. Design Single-institution, retrospective cohort study. Setting Tertiary children's hospital in an urban setting. Patients Patients with cleft lip and palate who underwent primary palatoplasty between 1996 and 2017 and had cone beam computed tomography (CBCT) prior to alveolar bone grafting. Interventions Primary palatoplasty with or without vomer flap. Main Outcomes Measure(s) The presence of a bony palatal bridge on pre-alveolar bone graft CBCT. Results Of 238 patients who underwent primary palatoplasty at a mean age of 10.0 months, 225 (94.5%) had a vomer flap. Bony palatal bridge formation was observed in 128 patients (53.8%) on pre-graft CBCT scans. Among patients with a bony palatal bridge, 121 (94.5%) had a vomer flap at primary palatoplasty. No significant association was found between use of a vomer flap and bony palatal bridge formation ( p = 0.996). Secondary analyses demonstrated no significant associations with age at primary palatoplasty ( p = 0.157), history of pre-surgical orthopedics ( p = 0.777), syndromic status ( p = 0.101), or cleft type ( p = 0.408). Conclusions This study demonstrated that the use of a vomer flap during primary cleft palate repair was not associated with the formation of a bony palatal bridge. Further studies will focus on other factors that may contribute to the etiology of bony palatal bridge formation.
2025-07-01 | Characterization and analysis of stem cells from human exfoliated deciduous teeth of children with and without cleft lip and palate
Background: Stem cells from human exfoliated deciduous teeth (SHED) have been considered a promising resource for regenerative medicine due to the ease of obtainment, noninvasive collection, and availability of deciduous teeth. Aims and Objectives: This study compared the characterization of SHED between children with and without cleft lip and palate (CLP), aiming at analyzing whether autologous SHED can be considered an option to be used as an alternative in the reconstruction of alveolar clefts in individuals with CLP. Materials and Methods: Dental pulp tissues were obtained from 6 healthy deciduous teeth at the exfoliation stage, from donors aged between 4 and 12 years, and divided into the control group and cleft group. The dental pulp cells obtained in the primary culture were immunophenotypically analyzed. Cells that showed positive for expressions of the cell surface markers and negative for were collected. The cells were submitted to multilineage differentiation and morphologically analyzed. The immunophenotypic difference between the groups was analyzed using Student’s t test, with a significance level of 5% ( P < 0.05). Results: Plastic adhesion was demonstrated and high levels of mesenchymal stem cell (MSC) markers were identified in both groups, with positive expression of CD105, CD73, and CD90 (≥95% positive) and absence of hematopoietic lineage markers CD45, CD34, CD11b, CD19, and HLA RD (≤2% positive). Pulp cells demonstrated capacity for adipogenic, osteogenic, and chondrogenic differentiation. The morphological analysis identified a slightly smaller nucleus and decreased proliferative capacity in the cleft group. There was a statistically significant difference ( P = 0.042) in the comparison of the cells obtained after immunophenotypic analysis between the groups. After validating the standard criteria for defining multipotent MSCs in both groups, the isolation and characterization of SHED were confirmed in all samples. Conclusion: SHED characterization of both groups was similar. These results suggest that SHED of children with CLP may be considered an option for future investigations on the autologous use of cells for therapeutic intervention.
oligonucleotides
2025-07-28 | LncRNA FENDRR Inhibits Mitochondrial Apoptosis via TET2-Mediated DNA Demethylation of MFN1 in NSCPO.
Non-syndromic cleft palate only (NSCPO) and non-syndromic cleft lip with or without cleft palate (NSCL/P) are distinct malformations with different or partially overlapping etiologies. While NSCL/P has been extensively studied, NSCPO remains relatively understudied. Emerging evidence suggests that long noncoding RNAs (lncRNAs) contribute to craniofacial development, potentially by regulating apoptosis. This study investigated the role of FENDRR, a lncRNA previously found to be downregulated in NSCL/P, in NSCPO pathogenesis. FENDRR expression in NSCPO tissues was analyzed via RT-qPCR and fluorescence in situ hybridization. Apoptosis in human embryonic palatal mesenchymal (HEPM) cells was assessed using Western blotting, flow cytometry, and TUNEL assays. Bioinformatics, methylation-specific PCR, dual-luciferase reporter assays, and RNA immunoprecipitation were employed to examine FENDRR's interaction with MFN1. FENDRR was significantly reduced in NSCPO tissues. FENDRR knockdown disrupted mitochondrial dynamics and activated mitochondrial apoptosis in HEPM cells. Mechanistically, FENDRR formed an RNA-DNA triplex with the MFN1 promoter, recruiting TET2 to promote MFN1 transcription via promoter demethylation. FENDRR enhances MFN1 expression, maintains mitochondrial fusion, and suppresses apoptosis in HEPM cells. This study provides novel insights into the regulatory role of lncRNAs in NSCPO pathogenesis and identifies FENDRR as a potential therapeutic target.
2024-05-26 | LAMA5: A new pathogenic gene for non-syndromic cleft lip with or without cleft palate.
This study aimed to investigate the effect of LAMA5 on palatal development in mice. The palatine process of C57BL/6 J fetal mice on the embryonic day 13.5 (E13.5) was cultured in vitro via the rotating culture method. The LAMA5-shRNA adenovirus vector was constructed, then transfected into the palatal process of E13.5 for 48 h in vitro. A fluorescence microscope was used to visualize the fusion of palates. The expression of LAMA5 was also detected. The expression of ki67, cyclin D1, caspase 3, E-cadherin, vimentin and SHH signaling pathway-related signaling factors in the blank control group, the negative control group, and the LAMA5 interference group were detected after virus transfection. The bilateral palates in the LAMA5 interference group were not fused after virus transfection. PCR and WB showed that the mRNA and protein expressions of LAMA5 were decreased in the LAMA5 interference group. Furthermore, the mRNA and protein expressions of ki67, cyclin D1 and gli1 were decreased in the LAMA5 interference group, while the mRNA and protein expressions of caspase 3 were increased. However, the mRNA and protein expression of E-cadherin, vimentin, Shh and ptch1 did not significantly change in the LAMA5 interference group. LAMA5 silencing causes cleft palate by inhibiting the proliferation of mouse palatal cells and promoting apoptosis, which may not be involved in EMT. LAMA5 silencing can also cause cleft palate by interfering with the SHH signaling pathway.
2024-02-27 | E-cadherin variants associated with oral facial clefts trigger aberrant cell motility in a REG1A-dependent manner
Abstract Background Germline mutations of E-cadherin contribute to hereditary diffuse gastric cancer (HDGC) and congenital malformations, such as oral facial clefts (OFC). However, the molecular mechanisms through which E-cadherin loss-of-function triggers distinct clinical outcomes remain unknown. We postulate that E-cadherin-mediated disorders result from abnormal interactions with the extracellular matrix and consequent aberrant intracellular signalling, affecting the coordination of cell migration. Methods Herein, we developed in vivo and in vitro models of E-cadherin mutants associated with either OFC or HDGC. Using a Drosophila approach, we addressed the impact of the different variants in cell morphology and migration ability. By combining gap closure migration assays and time-lapse microscopy, we further investigated the migration pattern of cells expressing OFC or HDGC variants. The adhesion profile of the variants was evaluated using high-throughput ECM arrays, whereas RNA sequencing technology was explored for identification of genes involved in aberrant cell motility. Results We have demonstrated that cells expressing OFC variants exhibit an excessive motility performance and irregular leading edges, which prevent the coordinated movement of the epithelial monolayer. Importantly, we found that OFC variants promote cell adhesion to a wider variety of extracellular matrices than HDGC variants, suggesting higher plasticity in response to different microenvironments. We unveiled a distinct transcriptomic profile in the OFC setting and pinpointed REG1A as a putative regulator of this outcome. Consistent with this, specific RNAi-mediated inhibition of REG1A shifted the migration pattern of OFC expressing cells, leading to slower wound closure with coordinated leading edges. Conclusions We provide evidence that E-cadherin variants associated with OFC activate aberrant signalling pathways that support dynamic rearrangements of cells towards improved adaptability to the microenvironment. This proficiency results in abnormal tissue shaping and movement, possibly underlying the development of orofacial malformations. Graphical Abstract
2023-07-13 | lncRNA MIR31HG Regulates Proliferation and Migration by Targeting Matrix Gla Protein in Nonsyndromic Cleft Lip With or Without Cleft Palate.
Nonsyndromic cleft lip with or without cleft palate (NSCL/P) is a common craniofacial birth defect with complex etiologies. Recently, the dysregulation of long noncoding RNAs (lncRNAs) has been implicated in many developmental diseases, including NSCL/P. However, the functions and mechanisms of lncRNAs in NSCL/P have not been fully elucidated. In this study, we found that lncRNA MIR31HG in NSCL/P patients was significantly downregulated than that in healthy individuals (GSE42589, GSE183527). In addition, single nucleotide polymorphism rs58751040 in MIR31HG was nominally associated with NSCL/P susceptibility (odds ratio: 1.29, 95% confidence interval: 1.03-1.54, p = 4.93 × 10-2) through a case-control study (504 NSCL/P cases and 455 controls). Luciferase activity assay showed that the C allele of rs58751040 revealed a decreased transcription activity of MIR31HG than the G allele. Moreover, knockdown of MIR31HG promoted cell proliferation and migration in human oral keratinocytes and human embryonic palate mesenchyme. Bioinformatic analysis and cellular studies suggested that MIR31HG may confer susceptibility to risk of NSCL/P through matrix Gla protein (MGP) signaling. In summary, we identified a novel lncRNA involved in the development of NSCL/P.
2023-04-21 | Long non-coding RNAs MALAT1 and NEAT1 in non-syndromic orofacial clefts.
Long non-coding RNAs (lncRNAs) are thought to play important roles in non-syndromic orofacial clefts (NSOFC). Clinical diagnosis was categorized as either non-syndromic cleft lip with or without cleft palate (NSCL/P), or non-syndromic cleft palate only (NSCPO). Tissues excised from the trimmed wound edge were reserved as experimental samples; adjacent normal control was used as a positive control, and tissue from healthy individuals was used as a blank control. Target lncRNAs in the collected tissues were identified using microarrays and quantitative reverse transcription PCR (RT-qPCR). Immunohistochemical (IHC) staining and RT-qPCR were used to verify the target mRNAs. Pathway, gene ontology (GO) enrichment, and TargetScan predictions were employed to construct competing endogenous RNA networks (ceRNA networks) and explore their potential functions. RNA-Seq revealed 24 upregulated and 43 downregulated lncRNAs; MALAT1 and NEAT1 were screened and validated using RT-qPCR. Common NSOFC risk factors were positively correlated with MALAT1 and NEAT1 expression. Bioinformatics predicted four ceRNA networks; GO enrichment focused on their potential functions. RT-qPCR and IHC data were consistent with respect to expression levels of proteins and the mRNAs that encode them. As MALAT1 and NEAT1 are associated with the severity of NSOFC, they represent potential therapeutic targets and prognostic biomarkers.
other
2025-11-30 | MOLAR-INCISOR HYPOMINERALIZATION ASSOCIATED WITH CLEFT LIP AND PALATE: CLINICAL EVIDENCE AND MANAGEMENT PERSPECTIVES
Cleft lip and palate are common congenital defects, affecting approximately one in every 650 live births in Brazil. In parallel, molar-incisor hypomineralization (MIH) is a defect that manifests as demarcated opacities that often affect the tooth enamel of first molars and permanent incisors. In patients with cleft lip and palate, factors such as bone graft surgery can contribute to MIH, which has a significantly high prevalence in this group. This study aimed to conduct a literature review on incisive molar hypomineralization in patients with cleft lip and palate, analyzing its prevalence compared to individuals without fissure, risk factors, clinical implications, challenges in the management and treatment of the condition. To this end, the review analyzed publications in databases such as PubMed/Medline, Scielo, and Scopus, using the following terms: MIH; pediatric dentistry; hypomineralization; cleft lip and palate; dental treatment; rehabilitation; and prevention. Results showed that, in the first stage, seven studies related MIH to cleft lip and palate, pointing to a higher prevalence in more complex cases, without addressing clinical management. In the second stage, nine high-evidence studies on the prevention and treatment of MIH in the general population were included, with protocols that could be adapted to patients with cleft lip and palate. In conclusion, MIH is more prevalent in patients with cleft lip and palate, especially in cases involving the palate and bilateral clefts. This condition compromises function, aesthetics, and quality of life, requiring individualized management with preventive strategies, sensitivity control, and adequate restorations.
2024-03-20 | METTL3-dependent m6A modification of PSEN1 mRNA regulates craniofacial development through the Wnt/β-catenin signaling pathway
Abstract Craniofacial malformations, often associated with syndromes, are prevalent birth defects. Emerging evidence underscores the importance of m 6 A modifications in various bioprocesses such as stem cell differentiation, tissue development, and tumorigenesis. Here, in vivo, experiments with zebrafish models revealed that mettl3 -knockdown embryos at 144 h postfertilization exhibited aberrant craniofacial features, including altered mouth opening, jaw dimensions, ethmoid plate, tooth formation and hypoactive behavior. Similarly, low METTL3 expression inhibited the proliferation and migration of BMSCs, HEPM cells, and DPSCs. Loss of METTL3 led to reduced mRNA m 6 A methylation and PSEN1 expression, impacting craniofacial phenotypes. Co-injection of mettl3 or psen1 mRNA rescued the level of Sox10 fusion protein, promoted voluntary movement, and mitigated abnormal craniofacial phenotypes induced by mettl3 knockdown in zebrafish. Mechanistically, YTHDF1 enhanced the mRNA stability of m 6 A-modified PSEN1 , while decreased METTL3-mediated m 6 A methylation hindered β-catenin binding to PSEN1, suppressing Wnt/β-catenin signaling. Pharmacological activation of the Wnt/β-catenin pathway partially alleviated the phenotypes of mettl3 morphant and reversed the decreases in cell proliferation and migration induced by METTL3 silencing. This study elucidates the pivotal role of METTL3 in craniofacial development via the METTL3/YTHDF1/PSEN1/β-catenin signaling axis.
2023-03-01 | Canonical Wnt signaling regulates soft palate development by mediating ciliary homeostasis
ABSTRACT Craniofacial morphogenesis requires complex interactions involving different tissues, signaling pathways, secreted factors and organelles. The details of these interactions remain elusive. In this study, we have analyzed the molecular mechanisms and homeostatic cellular activities governing soft palate development to improve regenerative strategies for individuals with cleft palate. We have identified canonical Wnt signaling as a key signaling pathway primarily active in cranial neural crest (CNC)-derived mesenchymal cells surrounding soft palatal myogenic cells. Using Osr2-Cre;β-cateninfl/fl mice, we show that Wnt signaling is indispensable for mesenchymal cell proliferation and subsequently for myogenesis through mediating ciliogenesis. Specifically, we have identified that Wnt signaling directly regulates expression of the ciliary gene Ttll3. Impaired ciliary disassembly leads to differentiation defects in mesenchymal cells and indirectly disrupts myogenesis through decreased expression of Dlk1, a mesenchymal cell-derived pro-myogenesis factor. Moreover, we show that siRNA-mediated reduction of Ttll3 expression partly rescues mesenchymal cell proliferation and myogenesis in the palatal explant cultures from Osr2-Cre;β-cateninfl/fl embryos. This study highlights the role of Wnt signaling in palatogenesis through the control of ciliary homeostasis, which establishes a new mechanism for Wnt-regulated craniofacial morphogenesis.
2019-02-28 | The use of botulinum toxin type A to minimize scarring in cleft lip repair: A literature review
Postsurgical scars can be a major concern for many patients. Young and Hutchison [1] found that patients were usually not satisfied with their surgical scars, with 91% stating that they would value any further improvement in their scars. Cleft lip with or without cleft palate is one of the most common congenital anomalies worldwide [2] [3]. Nonsyndromic cleft lip/palate affects approximately 1.5 to 2.5 cases per 1,000 live births, and its epidemiological distribution varies by ethnicity and geographic area [4] [5]. In today's culture, there is a major emphasis on facial appearances, largely driven by advances in social media. Individuals with deviations from what is considered "a normal look" may be socially stigmatized in their communities. Therefore, the final facial scar appearance remains a significant concern for affected individuals and their families. Herein, we review the process of wound healing and summarize the literature evaluating the effects of botulinum toxin type A (BTA) on scar formation in cleft lip repair.
2019-02-22 | The Role of the Wnt Signaling Pathway in Upper Jaw Development of Chick Embryo
Cleft lip with or without cleft palate (CLP) usually results from a failure of the medial nasal prominences to fuse with the lateral and maxillary prominences. This failure inhibits facial morphogenesis regulated by several major morphogenetic signaling pathways. We hypothesized that CLP results from the failure of the Wnt signaling pathway. To examine whether Wnt signaling can influences upper jaw development, we applied beads soaked with Dickkopf-1 (Dkk-1), Alsterpaullone (AL) or Wnt3a to the right side of the maxillary prominence of the chick embryo. The embryo showed a defect of the maxilla on the treated side, and skeletal staining revealed hypoplasia of the premaxilla and palatine bone as a result of Dkk-1-soaked bead implantation. 5-bromo-2'-deoxyuridine (BrdU)-positive cell numbers in the treated maxillary prominence were significantly lower at both 24 and 48 hr after implantation. Down-regulation of the expression of Bmp4, Tbx22, Sox9, and Barx1 was confirmed in the maxillary prominence treated with Dkk-1, which indicated that the deformity of the maxillary bone was controlled by gene targets of the Wnt signaling pathway. Expression of N-cadherin was seen immunohistochemically in the maxillary prominences of embryos at 6 hr and increased at 24 hr after AL treatment. Wnt signaling enhanced by AL or Wnt3a up-regulated the expression levels of Msx1, Bmp4, Tbx22, Sox9, and Barx1. Our data suggest that the Wnt signaling pathway regulates maxillary morphogenesis and growth through Bmp4, Tbx22, Sox9, and Barx1. Wnt signaling might regulate N-cadherin expression via Msx1, resulting in cell aggregation for osteochondrogenesis.
Access all drug discovery papers and probability of success in trials forecasts:
Access all drug discovery papers and probability of success in trials forecasts:
Drug Discovery Landscape
0 orphan drug designations.
0 orphan drug designations.
Let's accelerate rare disease drug discovery
Let's accelerate drug discovery
Get access to Explority AI’s forecasts to outperform average preclinical success rates. Whether you’re expanding your R&D pipeline, evaluating a partnership, or simply have a question — we’d love to hear from you.